Lyons C Neil 4
4 · CLEVELAND BIOLABS INC · Filed Jan 25, 2012
Insider Transaction Report
Form 4
Lyons C Neil
Chief Financial Officer
Transactions
- Award
Employee Stock Options (Right to Buy)
2012-01-23+18,750→ 18,750 totalExercise: $3.35From: 2012-01-23Exp: 2022-01-23→ Common Stock (18,750 underlying)
Footnotes (1)
- [F1]On January 23, 2012, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Mr. Lyons per the 2011 Executive Compensation Plan.